Treace Medical Concepts, Inc. provided revenue guidance for the full year 2022. The company expects revenue for the full year 2022 to range from $125 million to $130 million, which represents approximately 32% to 38% growth over the company's 2021 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.05 USD | +0.83% | +2.37% | -52.55% |
29/05 | Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing | MT |
17/05 | North American Morning Briefing : The "Everything -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.55% | 38Cr | |
+75.67% | 1.26TCr | |
-25.35% | 727.93Cr | |
+15.77% | 720.32Cr | |
+14.52% | 546.87Cr | |
-20.22% | 472.6Cr | |
+14.91% | 409.48Cr | |
-23.83% | 377.97Cr | |
-30.22% | 263.37Cr | |
+42.93% | 229.64Cr |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. Provides Revenue Guidance for the Full Year 2022